Literature DB >> 3012189

[Significance of leukotrienes in chronic respiratory tract diseases in childhood].

W Schönfeld, M Köller, J Knöller, W Müller, H vd Hardt, W König.   

Abstract

The role of lipoxygenase products was studied in children suffering from chronic diseases of the lung. Leukotrienes C4, D4, E4 and B4 were measured by high performance liquid chromatography (HPLC) and a specific radioimmunoassay (RIA) for C4. Elevated levels (up to 40 ng/ml), especially for leukotriene E4, were found in plasma of asthmatic and bronchitic patients (leukotriene C4 concentrations varied between 0.05 and 40 ng/ml, mean 4.9 +/- 7.8 ng/ml). In healthy donors the concentrations were below the detection limits of HPLC, leukotriene C4 ranging between 5 +/- 4 ng/ml (RIA data). The conversion of leukotriene C4 to D4 and E4 was observed by incubating the samples with synthetic leukotriene C4. The half-life of leukotriene C4 in plasma varied greatly, ranging from less than 12 min to 72 min (mean 39 +/- 16 min). Bronchial lavages yielded leukotriene C4 concentrations of 0.2 to 7 ng. Leukotriene E4 was detected in 10 of 41 cases. Conversion of leukotriene C4 did not occur in 50% of all cases, but was regularly observed in putrid lavages. These data suggest that leukotrienes play an important role in allergic and infectious lung diseases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3012189     DOI: 10.1007/bf01711931

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  22 in total

1.  The metabolism of leukotrienes in blood plasma studied by high-performance liquid chromatography.

Authors:  M Köller; W Schönfeld; J Knöller; K D Bremm; W König; B Spur; A Crea; W Peters
Journal:  Biochim Biophys Acta       Date:  1985-01-09

2.  Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acid.

Authors:  W König; H Tesch; N Frickhofen
Journal:  Eur J Immunol       Date:  1978-06       Impact factor: 5.532

3.  Subcellular localization of enzymes involved in leukotriene formation within human polymorphonuclear granulocytes.

Authors:  J Brom; M Raulf; M Stüning; B Spur; A Crea; K D Bremm; W König
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

4.  Formation of the cysteinyl form of slow reacting substance (leukotriene E4) in human plasma.

Authors:  C W Parker; D Koch; M M Huber; S F Falkenhein
Journal:  Biochem Biophys Res Commun       Date:  1980-12-16       Impact factor: 3.575

Review 5.  The pharmacology and pathophysiology of leukotriene B4.

Authors:  M A Bray
Journal:  Br Med Bull       Date:  1983-07       Impact factor: 4.291

6.  Bacteria and bacterial exotoxins induce leukotriene formation from human polymorphonuclear granulocytes.

Authors:  K D Bremm; H J Brom; W König; A Bohn; K Theobald; S Bhakdi; F Lutz; F J Fehrenbach
Journal:  Monogr Allergy       Date:  1983

Review 7.  Pharmacology of leukotrienes.

Authors:  P J Piper
Journal:  Br Med Bull       Date:  1983-07       Impact factor: 4.291

8.  The effect of leukotriene C4 and D4 on cutaneous blood flow in humans.

Authors:  H Bisgaard; J Kristensen; J Søndergaard
Journal:  Prostaglandins       Date:  1982-06

9.  Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy.

Authors:  J W Weiss; J M Drazen; E R McFadden; P Weller; E J Corey; R A Lewis; K F Austen
Journal:  JAMA       Date:  1983-05-27       Impact factor: 56.272

10.  Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4.

Authors:  S E Dahlén; G Hansson; P Hedqvist; T Björck; E Granström; B Dahlén
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

View more
  1 in total

1.  Leukotriene generation and metabolism in isolated human lung macrophages.

Authors:  W Schönfeld; B Schlüter; R Hilger; W König
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.